Can a culturally tailored lifestyle program help hispanic moms manage weight?
NCT ID NCT01868230
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a lifestyle intervention designed for overweight or obese Hispanic women during pregnancy. The program included diet and physical activity guidance to control weight gain and improve metabolic health. 232 women participated, and researchers measured weight changes and blood markers like glucose and cholesterol.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lifestyle intervention (diet and physical activity counseling)
- What this could lead to
- If successful, this approach could help reduce pregnancy-related weight gain and lower diabetes risk in Hispanic women.
- What could go wrong
- This is a completed trial, so results are available but may not apply to all populations. Lifestyle changes can be hard to maintain long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could diabetes be silently damaging your hearing?
- Press play on better health: could recording doctor visits boost Self-Care in seniors?
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- A simple card game could transform diabetes care
- Can a new injection help tackle obesity and diabetes? a safety trial begins